Ubiquitech Software Corp (OTCMKTS:UBQU) shares dipped 2.78% to $0.0175 on Tuesday and an additional 7.14% in after-hours trading. The company has a market cap of $1.81 million at 94.71 million shares outstanding. Share prices have been trading in a 52-week range of $0.01 to $0.06.
Ubiquitech Software Corp is a company that is engaged in the sale of dual subscriber identity module, dual-telephone-number mobile phone solutions with no contract, pre-paid unlimited text and voice. Its subsidiary Hemp Life Today offers CannazALL, which is a canabidiol oil made from domestically grown hemp.
In the press release, Ubiquitech Software Corp confirmed that legal filings are in progress and everything is being done to expedite the change of company name and symbol, which should offer greater flexibility and profit potential as the hemp industry continues to grow.
Also, the company announced that 2-4 new products would premiere this year and thus far has added two additional products, which are 800mg THC free Concentrated Oil and 1 gram (950mg) dabbing Shatter. It also announced its new NanoTech Infusion Process™ which adds more hemp plant materials to its CannazALL™ products.
Earlier in the month, the company started its direct mail advertising campaigns, which offered generous discounts to its buyers in subscriber lists, with the response being extremely positive.
Pending projects include new and improved packaging and company website, which is expected to be launched early next year. Also, Ubiquitech Software Corp is currently working with “Content Specific” sites that can act as Affiliate sellers of CannazALL™ CBD products such as PotGuide.com and ColoradoPotGuide.com. It also plans to create a new YouTube channel that will offer instructions and details on CannazALL™ products, dosing, and general information.
It concluded that the company is ahead of schedule in all aspects including its stated goals, sales, profits, and plans.
DISCLAIMER: There is a substantial risk of loss with any speculative asset, especially small cap stocks. The opinions expressed are those of the author, and do not constitute recommendations to buy or sell a stock. Do your own research before committing capital.
